IL17A and Behcet disease: According to a recent study, miR-23b expression may be downregulated in patients with BD, which may contribute to the activation of the Notch system and of Th1/Th17 cells, and CD4 T cells transfected with the miR-23b inhibitor markedly promoted both IL-17-expressing and IFN-γ-expressing T cells.